Nobel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency

Detalhes bibliográficos
Autor(a) principal: Coeli, Fernanda B.
Data de Publicação: 2010
Outros Autores: Soardi, Fernanda C., Bernardi, Renan D., Araujo, Marcela de, Paulino, Luciana C., Lau, Ivy F., Petroli, Reginaldo J., Lemos-Marini, Sofia H. V. de, Baptista, Maria T. M., Guerra-Junior, Gil, Mello, Maricilda Palandi de [UNIFESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1186/1471-2350-11-104
http://repositorio.unifesp.br/handle/11600/32634
Resumo: Background: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is caused by deletions, large gene conversions or mutations in CYP21A2 gene. the human gene is located at 6p21.3 within a locus containing the genes for putative serine/threonine Kinase RP, complement C4, steroid 21-hydroxylase CYP21 tenascin TNX, normally, in a duplicated cluster known as RCCX module. the CYP21 extra copy is a pseudogene (CYP21A1P). in Brazil, 30-kb deletion forming monomodular alleles that carry chimeric CYP21A1P/A2 genes corresponds to similar to 9% of disease-causing alleles. Such alleles are considered to result from unequal crossovers within the bimodular C4/CYP21 locus. Depending on the localization of recombination breakpoint, different alleles can be generated conferring the locus high degree of allelic variability. the purpose of the study was to investigate the variability of deleted alleles in patients with 21-hydroxylase deficiency.Methods: We used different techniques to investigate the variability of 30-kb deletion alleles in patients with 21-hydroxylase deficiency. Alleles were first selected after Southern blotting. the composition of CYP21A1P/A2 chimeric genes was investigated by ASO-PCR and MLPA analyses followed by sequencing to refine the location of recombination breakpoints. Twenty patients carrying at least one allele with C4/CYP21 30-kb deletion were included in the study.Results: An allele carrying a CYP21A1P/A2 chimeric gene was found unusually associated to a C4B/C4A Taq I 6.4-kb fragment, generally associated to C4B and CYP21A1P deletions. A novel haplotype bearing both p.P34L and p.H62L, novel and rare mutations, respectively, was identified in exon 1, however p.P30L, the most frequent pseudogene-derived mutation in this exon, was absent. Four unrelated patients showed this haplotype. Absence of p.P34L in CYP21A1P of normal controls indicated that it is not derived from pseudogene. in addition, the combination of different approaches revealed nine haplotypes for deleted 21-hydroxylase deficiency alleles.Conclusions: This study demonstrated high allelic variability for 30-kb deletion in patients with 21-hydroxylase deficiency indicating that a founder effect might be improbable for most monomodular alleles carrying CYP21A1P/A2 chimeric genes in Brazil.
id UFSP_28eb23364d44c0f61dc11e6a8bffee35
oai_identifier_str oai:repositorio.unifesp.br/:11600/32634
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Nobel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiencyBackground: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is caused by deletions, large gene conversions or mutations in CYP21A2 gene. the human gene is located at 6p21.3 within a locus containing the genes for putative serine/threonine Kinase RP, complement C4, steroid 21-hydroxylase CYP21 tenascin TNX, normally, in a duplicated cluster known as RCCX module. the CYP21 extra copy is a pseudogene (CYP21A1P). in Brazil, 30-kb deletion forming monomodular alleles that carry chimeric CYP21A1P/A2 genes corresponds to similar to 9% of disease-causing alleles. Such alleles are considered to result from unequal crossovers within the bimodular C4/CYP21 locus. Depending on the localization of recombination breakpoint, different alleles can be generated conferring the locus high degree of allelic variability. the purpose of the study was to investigate the variability of deleted alleles in patients with 21-hydroxylase deficiency.Methods: We used different techniques to investigate the variability of 30-kb deletion alleles in patients with 21-hydroxylase deficiency. Alleles were first selected after Southern blotting. the composition of CYP21A1P/A2 chimeric genes was investigated by ASO-PCR and MLPA analyses followed by sequencing to refine the location of recombination breakpoints. Twenty patients carrying at least one allele with C4/CYP21 30-kb deletion were included in the study.Results: An allele carrying a CYP21A1P/A2 chimeric gene was found unusually associated to a C4B/C4A Taq I 6.4-kb fragment, generally associated to C4B and CYP21A1P deletions. A novel haplotype bearing both p.P34L and p.H62L, novel and rare mutations, respectively, was identified in exon 1, however p.P30L, the most frequent pseudogene-derived mutation in this exon, was absent. Four unrelated patients showed this haplotype. Absence of p.P34L in CYP21A1P of normal controls indicated that it is not derived from pseudogene. in addition, the combination of different approaches revealed nine haplotypes for deleted 21-hydroxylase deficiency alleles.Conclusions: This study demonstrated high allelic variability for 30-kb deletion in patients with 21-hydroxylase deficiency indicating that a founder effect might be improbable for most monomodular alleles carrying CYP21A1P/A2 chimeric genes in Brazil.Univ Estadual Campinas, Lab Genet Mol Humana, Ctr Biol Mol & Engn Genet, Campinas, SP, BrazilUniv Estadual Campinas, Fac Ciencias Med, Dept Pediat, Ctr Invest Pediat, Campinas, SP, BrazilUniv Estadual Campinas, Fac Ciencias Med, Dept Clin Med, Disciplina Endocrinol, Campinas, SP, BrazilWeb of ScienceFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)FCSCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)FAPESP: 92/03332-6FAPESP: 97/07622-2FAPESP: 01/08150-4FAPESP: 05/00981-5FCS: 03/01785-0Biomed Central LtdUniversidade Estadual de Campinas (UNICAMP)Universidade Federal de São Paulo (UNIFESP)Coeli, Fernanda B.Soardi, Fernanda C.Bernardi, Renan D.Araujo, Marcela dePaulino, Luciana C.Lau, Ivy F.Petroli, Reginaldo J.Lemos-Marini, Sofia H. V. deBaptista, Maria T. M.Guerra-Junior, GilMello, Maricilda Palandi de [UNIFESP]2016-01-24T13:59:48Z2016-01-24T13:59:48Z2010-06-29info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion13application/pdfhttp://dx.doi.org/10.1186/1471-2350-11-104Bmc Medical Genetics. London: Biomed Central Ltd, v. 11, 13 p., 2010.10.1186/1471-2350-11-104WOS000283192200001.pdf1471-2350http://repositorio.unifesp.br/handle/11600/32634WOS:000283192200001engBmc Medical Geneticsinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-07T17:46:24Zoai:repositorio.unifesp.br/:11600/32634Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-07T17:46:24Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Nobel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency
title Nobel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency
spellingShingle Nobel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency
Coeli, Fernanda B.
title_short Nobel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency
title_full Nobel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency
title_fullStr Nobel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency
title_full_unstemmed Nobel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency
title_sort Nobel deletion alleles carrying CYP21A1P/A2 chimeric genes in Brazilian patients with 21-hydroxylase deficiency
author Coeli, Fernanda B.
author_facet Coeli, Fernanda B.
Soardi, Fernanda C.
Bernardi, Renan D.
Araujo, Marcela de
Paulino, Luciana C.
Lau, Ivy F.
Petroli, Reginaldo J.
Lemos-Marini, Sofia H. V. de
Baptista, Maria T. M.
Guerra-Junior, Gil
Mello, Maricilda Palandi de [UNIFESP]
author_role author
author2 Soardi, Fernanda C.
Bernardi, Renan D.
Araujo, Marcela de
Paulino, Luciana C.
Lau, Ivy F.
Petroli, Reginaldo J.
Lemos-Marini, Sofia H. V. de
Baptista, Maria T. M.
Guerra-Junior, Gil
Mello, Maricilda Palandi de [UNIFESP]
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual de Campinas (UNICAMP)
Universidade Federal de São Paulo (UNIFESP)
dc.contributor.author.fl_str_mv Coeli, Fernanda B.
Soardi, Fernanda C.
Bernardi, Renan D.
Araujo, Marcela de
Paulino, Luciana C.
Lau, Ivy F.
Petroli, Reginaldo J.
Lemos-Marini, Sofia H. V. de
Baptista, Maria T. M.
Guerra-Junior, Gil
Mello, Maricilda Palandi de [UNIFESP]
description Background: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is caused by deletions, large gene conversions or mutations in CYP21A2 gene. the human gene is located at 6p21.3 within a locus containing the genes for putative serine/threonine Kinase RP, complement C4, steroid 21-hydroxylase CYP21 tenascin TNX, normally, in a duplicated cluster known as RCCX module. the CYP21 extra copy is a pseudogene (CYP21A1P). in Brazil, 30-kb deletion forming monomodular alleles that carry chimeric CYP21A1P/A2 genes corresponds to similar to 9% of disease-causing alleles. Such alleles are considered to result from unequal crossovers within the bimodular C4/CYP21 locus. Depending on the localization of recombination breakpoint, different alleles can be generated conferring the locus high degree of allelic variability. the purpose of the study was to investigate the variability of deleted alleles in patients with 21-hydroxylase deficiency.Methods: We used different techniques to investigate the variability of 30-kb deletion alleles in patients with 21-hydroxylase deficiency. Alleles were first selected after Southern blotting. the composition of CYP21A1P/A2 chimeric genes was investigated by ASO-PCR and MLPA analyses followed by sequencing to refine the location of recombination breakpoints. Twenty patients carrying at least one allele with C4/CYP21 30-kb deletion were included in the study.Results: An allele carrying a CYP21A1P/A2 chimeric gene was found unusually associated to a C4B/C4A Taq I 6.4-kb fragment, generally associated to C4B and CYP21A1P deletions. A novel haplotype bearing both p.P34L and p.H62L, novel and rare mutations, respectively, was identified in exon 1, however p.P30L, the most frequent pseudogene-derived mutation in this exon, was absent. Four unrelated patients showed this haplotype. Absence of p.P34L in CYP21A1P of normal controls indicated that it is not derived from pseudogene. in addition, the combination of different approaches revealed nine haplotypes for deleted 21-hydroxylase deficiency alleles.Conclusions: This study demonstrated high allelic variability for 30-kb deletion in patients with 21-hydroxylase deficiency indicating that a founder effect might be improbable for most monomodular alleles carrying CYP21A1P/A2 chimeric genes in Brazil.
publishDate 2010
dc.date.none.fl_str_mv 2010-06-29
2016-01-24T13:59:48Z
2016-01-24T13:59:48Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1186/1471-2350-11-104
Bmc Medical Genetics. London: Biomed Central Ltd, v. 11, 13 p., 2010.
10.1186/1471-2350-11-104
WOS000283192200001.pdf
1471-2350
http://repositorio.unifesp.br/handle/11600/32634
WOS:000283192200001
url http://dx.doi.org/10.1186/1471-2350-11-104
http://repositorio.unifesp.br/handle/11600/32634
identifier_str_mv Bmc Medical Genetics. London: Biomed Central Ltd, v. 11, 13 p., 2010.
10.1186/1471-2350-11-104
WOS000283192200001.pdf
1471-2350
WOS:000283192200001
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Bmc Medical Genetics
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 13
application/pdf
dc.publisher.none.fl_str_mv Biomed Central Ltd
publisher.none.fl_str_mv Biomed Central Ltd
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268357329813504